Effects of terlipressin on patients with sepsis via improving tissue blood flow

Journal of Surgical Research

Volumn 200, Issue 1, 2015, Pages 274-282

  Xiao, Xudong ^a   Zhang, Jie ^a   Wang, Yaoli ^a   Zhou, Jian ^a   Zhu, Yu ^a   Jiang, Dongpo ^a   Liu, Liangming ^a   Li, Tao ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Early resuscitation goal; Septic shock; Side effect; Terlipressin; Vascular reactivity

Indexed keywords

BILIRUBIN; LACTIC ACID; NORADRENALIN; OXYGEN; TERLIPRESSIN; LYPRESSIN; VASOCONSTRICTOR AGENT;

ACID BASE BALANCE; ACUTE KIDNEY FAILURE; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ANURIA; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BLOOD FLOW VELOCITY; BLOOD OXYGEN TENSION; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HEMODYNAMICS; HUMAN; HYPONATREMIA; LACTATE BLOOD LEVEL; LOW DRUG DOSE; MALE; MORTALITY; OXYGEN THERAPY; PRIORITY JOURNAL; RADIAL ARTERY; RANDOMIZED CONTROLLED TRIAL; RESUSCITATION; SEPTIC SHOCK; SINGLE BLIND PROCEDURE; SINGLE DRUG DOSE; SURVIVAL RATE; THROMBOCYTE COUNT; TISSUE BLOOD FLOW; URINE VOLUME; ADOLESCENT; ANALOGS AND DERIVATIVES; BLOOD FLOW; COMBINATION DRUG THERAPY; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; DRUG EFFECTS; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; PATHOPHYSIOLOGY; SEPSIS; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ACID-BASE EQUILIBRIUM; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD COAGULATION; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HEMODYNAMICS; HUMANS; INFUSIONS, INTRAVENOUS; LYPRESSIN; MALE; MIDDLE AGED; NOREPINEPHRINE; REGIONAL BLOOD FLOW; SEPSIS; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS; YOUNG ADULT;

EID: 84938674998     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2015.07.016     Document Type: Article

References (35)

1. C. Brun-Buisson The epidemiology of the systemic inflammatory response Intensive Care Med 4 2000 S64
2. D.C. Angus, W.T. Linde-Zwirble, J. Lidicker, and et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care Crit Care Med 29 2001 1303
3. G.S. Martin, D.M. Mannino, S. Eaton, and M. Moss The epidemiology of sepsis in the United States from 1979 through 2000 N Engl J Med 348 2003 1546
4. J.L. Vincent, Y. Sakr, and C.L. Sprung Sepsis in European intensive care units: results of the SOAP study Crit Care Med 34 2006 344
5. S.T. Micek, N. Roubinian, and T. Heuring Before-after study of a standardized hospital order set for the management of septic shock Crit Care Med 34 2007 2707
6. F. Gao, T. Melody, and D.F. Daniels The impact of compliance with 6-hour and 24-hour sepsis bundles on hospital mortality in patients with severe sepsis: a prospective observational study Crit Care 9 2005 R764
7. S.M. Hollenberg, T.S. Ahrens, and D. Annane Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update Crit Care Med 32 2004 1928
8. C.L. Holmes, and K.R. Walley Vasoactive drugs for vasodilatory shock in ICU Curr Opin Crit Care 15 2009 398
9. D.W. Landry, and J.A. Oliver The pathogenesis of vasodilatory shock N Engl J Med 345 2001 588
10. G.M. Yang, L.M. Liu, J. Xu, and T. Li Effect of arginine vasopressin on vascular reactivity and calcium sensitivity after hemorrhagic shock in rats and its relationship to Rho-kinase J Trauma 12 2006 1336
11. E. Bassi, M. Park, and L.C. Azevedo Therapeutic strategies for high-dose vasopressor-dependent shock Crit Care Res Pract 2013 2013 654
12. G. Scarpati, and O. Piazza Vasopressin vs terlipressin in treatment of refractory shock Transl Med Unisa 5 2013 22
13. G.M. Yang, J. Xu, T. Li, and et al. Role of V1a receptor in AVP-induced restoration of vascular hyporeactivity and its relationship to MLCP-MLC20 phosphorylation pathway J Surg Res 161 2010 312
14. M. Salazar, B.B. Hu, J. Vazquez, R.L. Wintz, J. Varon, and et al. Exogenous vasopressin-induced hyponatremia in patients with vasodilatory shock: two case reports and literature review J Intensive Care Med 30 2015 253
15. J.A. Russell, K.R. Walley, J. Singer, and et al. Vasopressin versus norepinephrine infusion in patients with septic shock N Engl J Med 358 2008 877
16. C. Torgersen, M.W. Dünser, V. Wenzel, and et al. Comparing two different arginine vasopressin doses in advanced vasodilatory shock: a randomized, controlled, open-label trial Intensive Care Med 36 2010 57
17. T.A. Treschan, and J. Peters The vasopressin system: physiology and clinical strategies Anesthesiology 105 2006 599
18. G. Nilsson, P. Lindblom, M. Ohlin, R. Berling, and E. Vernersson Pharmacokinetics of terlipressin after single i.v. doses to healthy volunteers Drugs Exp Clin Res 16 1990 307
19. A. O'Brien, L. Calpp, and M. Singer Terlipressin for norepinephrine-resistant septic shock Lancet 359 2002 1209
20. N. Sepra, A.P. Nassar Júnior, S.O. Cardoso, and et al. Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials Crit Care 16 2012 R154
21. T.G. Kampmeier, S. Rehberg, M. Westphal, and M. Lange Vasopressin in sepsis and septic shock Minerva Anestesiol 76 2010 844
22. S. Rehberg, C. Ertmer, G. Köhler, and et al. Role of arginine vasopressin and terlipressin as first-line vasopressor agents in fulminant ovine septic shock Intensive Care Med 35 2009 1286
23. F. Ryckwaert, A. Virsolvy, A. Fort, and et al. Terlipressin, a provasopressin drug exhibits direct vasoconstrictor properties: consequences on heart perfusion and performance Crit Care Med 37 2009 876
24. R.P. Dellinger, P.M. Levy, and J.M. Carlet Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock Intensive Care Med 34 2008 17
25. M. Raghavan, and P.E. Marik Management of sepsis during the early "golden hours" J Emerg Med 3 2006 185
26. L.N. López-Bojórquez, A.Z. Dehesa, and G. Reyes-Terán Molecular mechanisms involved in the pathogenesis of septic shock Arch Med Res 35 2004 465
27. A.C. Mavrommatis, T. Theodoridis, A. Orfanidou, and et al. Coagulation system and platelets are fully activated in uncomplicated sepsis Crit Care Med 28 2000 451
28. M. Leone, J. Albanèse, and A. Delmas Terlipressin in catecholamine-resistant septic shock patients Shock 22 2004 314
29. L. Günter, M.W. Dünser, and J. Stefan Arginine vasopressin in 316 patients with advanced vasodilatory shock Crit Care Med 33 2005 2659
30. E. Rivers, B. Nguyen, S. Havstad, et al. Early Goal-Directed Therapy Collaborative Group Early goal-directed therapy in the treatment of severe sepsis and septic shock N Engl J Med 345 2001 1368
31. J. Albanèse, M. Leone, A. Delmas, and C. Martin Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study Crit Care Med 33 2005 1897
32. A. Morelli, C. Ertmer, S. Rehberg, and et al. Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study Crit Care 13 2009 R130
33. X. Xiao, Y. Zhu, D. Zhen, and et al. Beneficial and side effects of arginine vasopressin and terlipressin for septic shock J Surg Res 195 2015 568
34. G.M. Yang, T. Li, J. Xu, and L.M. Liu PKC plays an important mediated effect in arginine vasopressin induced restoration of vascular responsiveness and calcium sensitization following hemorrhagic shock in rats Eur J Pharmacol 628 2010 148
35. J. Xu, T. Li, G.M. Yang, and L.M. Liu Protein kinase C isoforms responsible for the regulation of vascular calcium sensitivity and their relationship to integrin-linked kinase pathway after hemorrhagic shock J Trauma 69 2010 1274